Sectra adds autonomous chest X-ray AI through Oxipit acquisition
The deal gives Sectra ownership of ChestLink, Oxipit’s CE Class IIb-certified autonomous AI product for chest X-ray analysis.
Sectra has completed its acquisition of Oxipit, a Lithuanian developer of autonomous AI for radiology. The company said the deal strengthens its portfolio of regulatory-approved AI tools for diagnostic imaging.
With the deal closed, Sectra now owns and plans to further develop ChestLink, Oxipit’s flagship product. Sectra described the software as an autonomous AI tool for chest X-ray analysis.
ChestLink automatically identifies and clears high-confidence normal chest X-rays from the radiology worklist, according to Sectra. The company said this allows radiologists to focus on cases with a higher probability of disease.
Sectra said the product holds CE Class IIb certification for autonomous chest X-ray analysis. The certification permits commercialization within the European Economic Area, according to the company.
In March, Sectra said Oxipit’s products were already deployed across multiple international markets. Oxipit’s portfolio includes CE-marked AI tools spanning chest X-ray, CT, and musculoskeletal imaging.
Financial terms were not disclosed. Sectra said in March that the acquisition would be financed using its own funds and was not expected to materially affect group sales or operating profit for the current year.
Oxipit’s team will operate as a dedicated AI development center within Sectra’s Imaging IT Solutions business area, according to the earlier acquisition announcement. Sectra said its Amplifier service will remain an open, vendor-neutral AI marketplace.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST Pro brings contrast tracking upgrade to U.S. cath labs
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.
Braid Health launches $199 radiology second-opinion service
Patients can upload MRI, CT, X-ray, or ultrasound files and receive a written second opinion from a board-certified U.S. radiologist.
QT Imaging prices $10M raise for breast imaging platform
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.
PSMA PET guidance anchors EDAP-Telix HIFU prostate work
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.
UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.
Lumexa adds 4 imaging centers, including first UPMC JV site
Lumexa Imaging added 4 outpatient imaging centers across Pennsylvania, North Carolina, South Carolina, and Florida. The expansion includes acquired centers through joint ventures with UPMC and Advocate Health, plus 2 newly built locations.
PAI report finds 82% of U.S. physicians are now employed
A new PAI-Avalere report found that 82% of U.S. physicians are employed by hospitals, health systems, or corporate entities. Physician-owned settings now account for 18% of physicians and 36.1% of practices.